In KRAS-mutant CRC cells, combination treatment with β-elemene and cetuximab enhanced the cytotoxic effect against cancer cells by inducing ferroptosis and inhibiting EMT (29). The gene discussed is KRAS; the disease is colorectal carcinoma.